Methotrexate BP / EP / IP / USP

Product Name : Methotrexate

CAS : 59-05-2

Molecular Formula : C20H22N8O5

Molecular Weight : 454.4 g/mol

Pharmaceutical Grade : BP / EP / IP / USP

Therapeutic Category : Anticancer, Antineoplastic


Global Calcium is one of the leading manufacturers and exporters of Methotrexate CAS no. 59-05-2, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.

As manufacturer of Methotrexate we hereby state the following facts about the drug:

Antineoplastic Agent: Methotrexate is combined with anti-TNF agents and shown effective in the management of patients with lymphoma (non-Hodgkin's type), carcinoma of the breast, small-cell carcinoma of the lung, epidermal tumors of the head and neck, and carcinoma of the ovary, lymphoblastic leukemia, head and neck cancer, osteosarcoma etc.

Rheumatoid Arthritis: Methotrexate is an FDA-approved folic acid antagonist indicated for the treatment of rheumatoid arthritis because of its high potency and efficacy in such patients; it can also be useful in patients with juvenile idiopathic arthritis.

Antifungal: Methotrexate is used off-lain cases of mycosis fungoides, dermatomyositis, pityriasis rubra pilaris, eczema, and sarcoidosis.

Other uses: Methotrexate is also safe and effective for patients with psoriasis, systemic lupus erythematosus, inflammatory bowel disease, vasculitis, and many other connective tissue diseases. The medication is also effective in patients with organ transplantation because of its anti-inflammatory and immunomodulatory activity.

Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market